FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
36 letters match. Newest first.
-
DrugsCheap Medicine Shop/www.cheapmedicineshop.com
FDA warned India-based website Cheap Medicine Shop for selling unapproved, misbranded injectable semaglutide to U.S. consumers.
High risk -
DrugsRoyal Peptides LLC
FDA warned Royal Peptides LLC that seven peptide products sold on its website are unapproved new drugs.
High risk -
DrugsTXP Innovations LLC dba Tex Peptides
FDA warned Dallas peptide seller TXP Innovations (Tex Peptides) that its website sells unapproved injectable drugs, including semaglutide and tirzepatide.
High risk -
DrugsMedica Weight Loss
FDA warns telehealth seller Medica Weight Loss that its compounded semaglutide and tirzepatide web claims are false and misbrand the drugs.
Medium -
DrugsReady Med
FDA warned Ready Med over website claims that compounded semaglutide and tirzepatide products were FDA-approved or FDA-licensed.
Low -
DrugsGuangzhou Huli Technology Co., Ltd. dba Fantasy Face
FDA warned Guangzhou Huli Technology (dba Fantasy Face) for selling an unapproved GLP-1 weight loss drug online.
Medium -
DrugsPrime Sciences
Prime Sciences sells injectable peptide drugs and BAC water online without FDA approval, FDA says.
High risk -
DrugsFormPour
FDA warned FormPour over selling an unapproved new drug, SMGT-GLT-1 Nano Microneedle Patch, on eBay.
High risk -
DrugsMile High Compounds LLC
FDA warned Mile High Compounds that it sells unapproved injectable GLP-1-like drugs and BAC water online.
High risk -
DrugsPekCura Labs
FDA warned PekCura Labs that its GLP-1-S, GLP-2-T, GLP-3-R, and bacteriostatic water products are unapproved new drugs sold online.
High risk -
DrugsZeuss LLC dba Zeuss
FDA warned telehealth seller Zeuss that its website misbrands compounded tirzepatide by implying Zeuss makes it and that it is FDA-approved.
Medium -
DrugsPeaks Curative, LLC dba Peaks
FDA warned Peaks Curative over false or misleading website claims for compounded (pharmacy-made) semaglutide, including implied FDA approval.
Low -
DrugsApotex Inc.
FDA cited Apotex's Richmond Hill sterile plant for failed investigations and aseptic contamination risks, prompting recalls.
High risk -
DrugsFWD Care, Inc. dba FWD
FDA warned telehealth company FWD Care that its website claims for compounded semaglutide and tirzepatide drugs are false or misleading.
Medium -
DrugsVitals RX
FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.
Medium -
DrugsLyfe Rx
Lyfe Rx offered compounded semaglutide and tirzepatide online with false 'clinically proven weight loss' claims, FDA says.
Low -
DrugsSlendid
FDA warned Slendid that its website sells compounded semaglutide and tirzepatide with a false "clinically proven" claim, making the drugs misbranded.
Medium -
DrugsMane & Steel, LLC. dba Mane & Steel
FDA warns Mane & Steel over false 'clinically proven' claims for compounded semaglutide.
Low -
DrugsLumimeds
FDA warns Lumimeds over website claims implying its compounded semaglutide and tirzepatide are FDA-approved.
High risk -
DrugsCanada Med Stop
Canada Med Stop marketed compounded semaglutide online as FDA-approved and generic, making the drugs misbranded.
Medium -
DrugsDr. Gater’s Weight Loss & Wellness
Dr. Gater’s Weight Loss & Wellness marketed compounded semaglutide and tirzepatide with false or misleading FDA-approval and generic-Ozempic claims.
Medium -
DrugsHealthon Inc. dba Healthon
FDA warned Healthon over unapproved compounded semaglutide and tirzepatide sold online with false 'FDA-approved' and 'same as' claims.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly’s Oprah-linked video for Zepbound and Mounjaro misled on serious risks.
High risk -
DrugsNovo Nordisk Inc.
FDA says Novo Nordisk’s Oprah Winfrey video makes Wegovy, Ozempic and Victoza look safer than their labels allow.
High risk -
DrugsPrime Vitality, Inc. dba Prime Peptides
FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.
High risk -
DrugsVeronvy
FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."
Medium -
DrugsNomida.biz
FDA warned Nomida.biz over its website selling unapproved and misbranded semaglutide and tirzepatide drugs to U.S. consumers.
High risk -
DrugsUS Chem Labs
FDA warned US Chem Labs that it sells unapproved and misbranded Semaglutide, Tirzepatide, and Thymalin drugs online.
High risk -
Drugswww.semaspace.com
FDA warned semaspace.com for selling unapproved, misbranded injectable semaglutide drugs online without prescriptions.
High risk -
DrugsiSlim, LLC
FDA warned iSlim, LLC that its Alfia Weight Loss Capsules are an unapproved, misbranded drug containing undeclared sibutramine.
High risk -
DrugsHIS Enterprise Inc dba Adam’s Secret USA, LLC
FDA: Adam's Secret and Dr. Reade Slim Sense supplements sold online contain hidden prescription drugs tadalafil, sildenafil and lorcaserin.
High risk -
DrugsVitaCig, Inc.
FDA warned VitaCig that its flavored inhalers and capsules are unapproved new drugs sold with disease-treatment claims on its website.
High risk -
FoodNew York Nutrition Company / American Metabolix
FDA says New York Nutrition/American Metabolix sold supplements with unapproved drug claims and unsafe additives Hordenine HCl and Higenamine HCl.
High risk -
FoodLysulin, Inc.
Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.
High risk -
DrugsGenesis Nutrition Ultra Slim dba Genesis Ultra Slim
Genesis Nutrition Ultra Slim sells Genesis Ultra Slim Gold, a weight-loss product that contains undeclared sibutramine and phenolphthalein.
High risk -
DrugsJe Dois Lavoir LLC
Je Dois Lavoir sells 365 Skinny High Intensity weight-loss drug containing undeclared sibutramine without FDA approval.
High risk